Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MNC Round Table Meeting On China’s Pharmaceutical Industry

This article was originally published in PharmAsia News

Executive Summary

The Economist Group recently hosted a round table meeting on China's pharmaceutical industry in Shanghai. More than 100 companies including Bayer, AstraZeneca, Roche, Bristol-Myers Squibb, Boehringer Ingelheim, Fosun, Simcere, Xinhua Pharmaceutical and IMS Health attended the event to discuss the challenges of operating in the market. Obstacles including the industry's integration, promotion of health insurance, health care reform, population change and wealth accumulation of urban residents will come together to change the country's pharmaceutical landscape. The Economist Group predicts the average growth rate of China's market will be 8 percent for the next five years. Strong demands brought about by an aging population, increasing economic level and government investment in health care make China even more attractive among the emerging markets. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067361

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel